UnicoCell Biomed Co., Ltd. (6794.TW)

TWD 70.8

(0.28%)

Revenue Summary of UnicoCell Biomed Co., Ltd.

  • UnicoCell Biomed Co., Ltd.'s latest annual revenue in 2023 was 24.58 Million TWD , up 70.79% from previous year.
  • UnicoCell Biomed Co., Ltd.'s latest quarterly revenue in 2024 Q2 was 3.7 Million TWD , up 38.88% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported a annual revenue of 14.39 Million TWD in annual revenue 2022, up 76.07% from previous year.
  • UnicoCell Biomed Co., Ltd. reported a annual revenue of 8.17 Million TWD in annual revenue 2021, up 105.35% from previous year.
  • UnicoCell Biomed Co., Ltd. reported a quarterly revenue of 2.66 Million TWD for 2024 Q1, down -57.88% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported a quarterly revenue of 6.33 Million TWD for 2023 Q3, down -21.47% from previous quarter.

Annual Revenue Chart of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Historical Annual Revenue of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Year Revenue Revenue Growth
2023 24.58 Million TWD 70.79%
2022 14.39 Million TWD 76.07%
2021 8.17 Million TWD 105.35%
2020 3.98 Million TWD -74.7%
2019 15.73 Million TWD 0.0%

Peer Revenue Comparison of UnicoCell Biomed Co., Ltd.

Name Revenue Revenue Difference
Apex Biotechnology Corp. 1.67 Billion TWD 98.533%
Sinphar Pharmaceutical Co.,Ltd. 2.96 Billion TWD 99.17%
Panion & Bf Biotech Inc. 1.88 Billion TWD 98.693%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 2.08 Billion TWD 98.821%
GenMont Biotech Incorporation 318.01 Million TWD 92.268%
Abnova (Taiwan) Corporation 382.05 Million TWD 93.564%
Adimmune Corporation 1.78 Billion TWD 98.623%
Tanvex BioPharma, Inc. 61.41 Million TWD 59.96%
Polaris Group 7.48 Million TWD -228.686%
Energenesis Biomedical CO.,LTD. 7.15 Million TWD -243.518%
PELL Bio-Med Technology Co. Ltd. 18.03 Million TWD -36.356%